KR20240041952A - Nirf 이미징용 푸덱사시아니늄 - Google Patents

Nirf 이미징용 푸덱사시아니늄 Download PDF

Info

Publication number
KR20240041952A
KR20240041952A KR1020247005443A KR20247005443A KR20240041952A KR 20240041952 A KR20240041952 A KR 20240041952A KR 1020247005443 A KR1020247005443 A KR 1020247005443A KR 20247005443 A KR20247005443 A KR 20247005443A KR 20240041952 A KR20240041952 A KR 20240041952A
Authority
KR
South Korea
Prior art keywords
fudexacyaninium
dose
pharmaceutical composition
free form
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247005443A
Other languages
English (en)
Korean (ko)
Inventor
마사코 사이토
간지 고마츠
신 다쿠사가와
레티시아 델가도-헤레라
Original Assignee
아스테라스 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스테라스 세이야쿠 가부시키가이샤 filed Critical 아스테라스 세이야쿠 가부시키가이샤
Publication of KR20240041952A publication Critical patent/KR20240041952A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020247005443A 2021-07-28 2022-07-27 Nirf 이미징용 푸덱사시아니늄 Pending KR20240041952A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226534P 2021-07-28 2021-07-28
US63/226,534 2021-07-28
PCT/IB2022/056957 WO2023007404A1 (en) 2021-07-28 2022-07-27 Pudexacianinium for nirf imaging

Publications (1)

Publication Number Publication Date
KR20240041952A true KR20240041952A (ko) 2024-04-01

Family

ID=82898903

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247005443A Pending KR20240041952A (ko) 2021-07-28 2022-07-27 Nirf 이미징용 푸덱사시아니늄

Country Status (9)

Country Link
US (1) US20240342316A1 (https=)
EP (1) EP4376896A1 (https=)
JP (1) JP2024527715A (https=)
KR (1) KR20240041952A (https=)
CN (1) CN117715661A (https=)
AU (1) AU2022321011A1 (https=)
CA (1) CA3226034A1 (https=)
MX (1) MX2024001242A (https=)
WO (1) WO2023007404A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4605020A1 (en) * 2022-10-21 2025-08-27 Astellas Pharma, Inc. Composition for near infrared lymphatic imaging and uses and dosages therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041616T2 (hu) 2010-01-28 2019-05-28 National Univ Corporation Mie Univ Indocianin vegyület, szintézisének eljárása, tisztítási eljárása, indocianin vegyületet alkalmazó diagnosztikai készítmény, és készülék in vivo kinetika mérésére és készülék keringés megjelenítésére a diagnosztikai készítmény alkalmazásával

Also Published As

Publication number Publication date
CA3226034A1 (en) 2023-02-02
US20240342316A1 (en) 2024-10-17
CN117715661A (zh) 2024-03-15
WO2023007404A1 (en) 2023-02-02
MX2024001242A (es) 2024-02-13
AU2022321011A1 (en) 2024-01-25
EP4376896A1 (en) 2024-06-05
JP2024527715A (ja) 2024-07-26

Similar Documents

Publication Publication Date Title
US9149537B2 (en) Compositions and methods for the treatment of traumatic brain injury
TWI486161B (zh) 含那若松（ｎａｌｏｘｏｎｅ）的鼻內藥物劑型
JP5449784B2 (ja) 抗癌用途のためのドキソルビシン製剤
JP2017081930A (ja) ラキニモドおよび酢酸グラチラマーを組み合わせた多発性硬化症の治療
JP7830313B2 (ja) アルコール性肝炎の処置
KR20240041952A (ko) Nirf 이미징용 푸덱사시아니늄
US20200000941A1 (en) Compositions and methods for measuring and expanding blood volume
JP3415643B2 (ja) 筋ジストロフィー症治療薬
JP7618235B2 (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
Xu et al. CPL-01, an investigational long-acting ropivacaine, exhibits extended-release properties after mini-abdominoplasty
Stern et al. Correlation between pancreatic polypeptide response to secretin and ERCP findings in chronic pancreatitis.
RU2857200C2 (ru) Лекарственное средство dc009 для лечения острого ишемического инсульта
HK40104552A (zh) 用於nirf成像的普地沙铵
US20240016794A1 (en) Method for treating acute ischemic stroke
JP6706632B2 (ja) 半月板変性治療用組成物
EP4311539A1 (en) Imatinib formulation for parenteral administration
JP2008534521A (ja) ピリドキサール５’−リン酸の静脈用製剤、調製方法、およびその使用
JP2026071350A (ja) 疾患用の医薬ヒドロニドン製剤
WO2025010379A2 (en) Glutathione-responsive methotrexate polymersomes for management of ectopic pregnancy
TW200302104A (en) A pharmaceutical composition comprising SANORG34006 for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
Pethö et al. Influence of diltiazem on postischemic microcirculation and function in the rat kidney
KR20200068643A (ko) Fgfr 선택적 티로신 키나제 억제제를 포함하는 약제학적 조성물
Lefèvre et al. Nebulized opioid analgesia: a comparative study of morphine, fentanyl and alfentanyl
Swahn et al. Mo1361 Rendezvous ERCP Technique Results in Fewer Cases of Post-ERCP-Pancreatitis Compared With Conventional Cannulation Technique. A Prospective Nationwide Population-Based Cohort Study in Sweden
JPS60130520A (ja) 脳卒中予防・治療剤

Legal Events

Date Code Title Description
PA0105 International application
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250521

Comment text: Request for Examination of Application